Evolutionary Genomics, Inc. (FNAM) SEC Filing 10-Q Quarterly Report for the period ending Thursday, March 31, 2022

SEC Filings

FNAM Quarterly Reports

Evolutionary Genomics, Inc.

CIK: 884363 Ticker: FNAM
3 Months Ended
Mar. 31, 2022
Cover [Abstract] 
Document Type10-Q
Amendment Flagfalse
Document Quarterly Reporttrue
Document Transition Reportfalse
Document Period End DateMar. 31, 2022
Document Fiscal Period FocusQ1
Document Fiscal Year Focus2022
Current Fiscal Year End Date--12-31
Entity File Number000-54129
Entity Central Index Key0000884363
Entity Tax Identification Number26-4369698
Entity Incorporation, State or Country CodeNV
Entity Address, Address Line One4220 Morning Star Drive
Entity Address, City or TownCastle Rock
Entity Address, State or ProvinceCO
Entity Address, Postal Zip Code80108
City Area Code(720)
Local Phone Number900-8666
Entity Current Reporting StatusYes
Entity Interactive Data CurrentYes
Entity Filer CategoryNon-accelerated Filer
Entity Small Businesstrue
Entity Emerging Growth Companyfalse
Entity Shell Companyfalse
Entity Common Stock, Shares Outstanding6,615,231

View differences made from one quarter to another to evaluate Evolutionary Genomics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Evolutionary Genomics, Inc..


Assess how Evolutionary Genomics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Evolutionary Genomics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Evolutionary Genomics, Inc. provided additional information to their SEC Filing as exhibits

Ticker: FNAM
CIK: 884363
Form Type: 10-Q Quarterly Report
Accession Number: 0001553350-22-000464
Submitted to the SEC: Mon May 16 2022 4:14:18 PM EST
Accepted by the SEC: Mon May 16 2022
Period: Thursday, March 31, 2022
Industry: Commercial Physical And Biological Research

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: